Highland Therapeutics Announces Appointment Of Craig S. Lewis To Board Of Directors

TORONTO--(BUSINESS WIRE)--Highland Therapeutics Inc. (“Highland”) today announced that its U.S. subsidiary, Ironshore Pharmaceuticals (America) Inc. (“IPA”), has appointed Craig S. Lewis to its Board of Directors. Mr. Lewis brings a proven track record to IPA along with a wealth of commercial leadership and strategy experience gained during a 30+ year career in the pharmaceutical and medical device industries.

Help employers find you! Check out all the jobs and post your resume.